Tag: Josh Shin
Firms act on USD2.5bn US-Korean AI-driven drug discovery pact
Firms assists on US-South Korea AI driven drug discovery collaboration between Insilico Medicine and SK Biopharmaceuticals
Investors ride wave of cross-border biomedical acquisitions
Amid the cool capital markets climate, the recent surge in billion-dollar M&A deals involving overseas biomedical companies



















